Overview
My research is broadly focused on elucidating the complex interactions that exist between the host microbiome and exogenous pathogens that cause infections in children. We have several ongoing projects evaluating: 1) the impact of the upper respiratory microbiome on the risk of colonization and invasion by bacterial respiratory pathogens among infants in Botswana; 2) associations between the gut microbiome of pediatric stem cell transplant recipients and the risk of infections (bloodstream infection, C. difficile infection) and graft-versus-host disease; and 3) the role of the gut and respiratory microbiomes in mediating COVID-19 infection susceptibility and disease severity in children. Ultimately, I aim to develop strategies that use targeted modification of the microbiome for the prevention of infections in children.
Current Appointments & Affiliations
Adjunct Associate Professor of Pediatrics
·
2025 - Present
Pediatrics, Infectious Diseases,
Pediatrics
Member of the Human Vaccine Institute
·
2024 - Present
Duke Human Vaccine Institute,
Institutes and Centers
Recent Publications
Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis.
Journal Article Pharmacoecon Open · May 2026 BACKGROUND: Pneumococcal disease and post-meningitis sequelae (PMS) impact health-related quality of life (HRQoL). However, health utility estimates for these conditions vary considerably in the literature, which may affect the outcomes of economic evaluat ... Full text Link to item CiteEarly life factors documented in electronic health records predict recurrent acute otitis media
Preprint · March 9, 2026 Full text CiteGlobal Assessment of Health Utilities Associated with Pneumococcal Disease in Adults: Targeted Literature Reviews.
Journal Article Pharmacoecon Open · January 2026 BACKGROUND: Pneumococcal disease can significantly reduce quality of life (QoL). Health utilities are commonly used to assess QoL burden and calculate quality-adjusted life years (QALYs), which are critical inputs in cost-utility analyses (CUAs) to evaluat ... Full text Link to item CiteRecent Grants
Role of C difficile Colonization in Risk of Disease
ResearchCo-Mentor · Awarded by National Institutes of Health · 2025 - 2030The Gut Microbiome and Development of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation in Children
ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030Unified Program for Therapeutics in Children
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030View All Grants
Education
Harvard Medical School ·
2007
M.D.
Harvard University ·
2007
M.P.H.